{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:48:35Z","timestamp":1793407715257,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The dual-hit hypothesis of Parkinson\u2019s disease (PD) originally postulated that a neurotropic pathogen leads to formation of \u03b1-synuclein pathology in the olfactory bulb (OB) and dorsal motor nucleus of the vagus (DMV) and then invades the brain from these two entry points. Little work has been conducted to validate an important underlying premise for the dual-hit hypothesis, namely that the initial Lewy pathology does arise simultaneously in the OB and the enteric nervous system (ENS) plexuses and DMV at the earliest disease stage. We conducted a focused re-analysis of two postmortem datasets, which included large numbers of mild Lewy body disease (LBD) cases. We found that cases with \u03b1-synuclein pathology restricted to the peripheral autonomic nervous system and\/or lower brainstem (early body-first LBD cases) very rarely had any OB pathology, suggesting that Lewy pathology commonly arises in the ENS without concomitant involvement of the OB. In contrast, cases with mild amygdala-predominant Lewy pathology (early brain-first LBD cases) nearly always showed OB pathology. This is compatible with the first pathology being triggered in the OB or amygdala followed by secondary spreading to connected structures, but without early involvement of the ENS or lower brainstem. These observations support that the pathologic process starts in\n                    <jats:italic>either<\/jats:italic>\n                    the olfactory bulb\n                    <jats:italic>or<\/jats:italic>\n                    the ENS, but rarely in the olfactory bulb and gut simultaneously. More studies on neuropathological datasets are warranted to reproduce these findings. The agreement between the revised single-hit hypothesis and the recently proposed brain-first vs. body-first model of LBD is discussed.\n                  <\/jats:p>","DOI":"10.1038\/s41531-022-00436-2","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T07:03:54Z","timestamp":1669791834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-8052","authenticated-orcid":false,"given":"Per","family":"Borghammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie Kristine","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Horsager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2823-8785","authenticated-orcid":false,"given":"Casper","family":"Skj\u00e6rb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Raunio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-9749","authenticated-orcid":false,"given":"Eloise H.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Savola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Myllykangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Van Den Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"436_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak, H., Rub, U., Gai, W. P. & Del Tredici, K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural Transm. 110, 517\u2013536 (2003).","journal-title":"J. Neural Transm."},{"key":"436_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes, C. H., Del Tredici, K. & Braak, H. Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 33, 599\u2013614 (2007).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"436_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg, D. et al. Prodromal Parkinson disease subtypes\u2014key to understanding heterogeneity. Nat. Rev. Neurol. 17, 349\u2013361 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"436_CR4","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/mds.26605","volume":"31","author":"CH Adler","year":"2016","unstructured":"Adler, C. H. & Beach, T. G. Neuropathological basis of nonmotor manifestations of Parkinson\u2019s disease. Mov. Disord. 31, 1114\u20131119 (2016).","journal-title":"Mov. Disord."},{"key":"436_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00401-013-1160-3","volume":"126","author":"NL Rey","year":"2013","unstructured":"Rey, N. L., Petit, G. H., Bousset, L., Melki, R. & Brundin, P. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 126, 555\u2013573 (2013).","journal-title":"Acta Neuropathol."},{"key":"436_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge, N. et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol. 138, 535\u2013550 (2019).","journal-title":"Acta Neuropathol."},{"key":"436_CR7","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.3233\/JPD-191721","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer, P. & Van Den Berge, N. Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis. J. Parkinson\u2019s Dis. 9, S281\u2013S295 (2019).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"436_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/mds.27556","volume":"34","author":"DP Breen","year":"2019","unstructured":"Breen, D. P., Halliday, G. M. & Lang, A. E. Gut-brain axis and the spread of alpha-synuclein pathology: vagal highway or dead end? Mov. Disord. 34, 307\u2013316 (2019).","journal-title":"Mov. Disord."},{"key":"436_CR9","doi-asserted-by":"publisher","first-page":"105599","DOI":"10.1016\/j.nbd.2021.105599","volume":"163","author":"N Van Den Berge","year":"2022","unstructured":"Van Den Berge, N. & Ulusoy, A. Animal models of brain-first and body-first Parkinson\u2019s disease. Neurobiol. Dis. 163, 105599 (2022).","journal-title":"Neurobiol. Dis."},{"key":"436_CR10","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/brain\/awaa096","volume":"143","author":"ML Arotcarena","year":"2020","unstructured":"Arotcarena, M. L. et al. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. Brain 143, 1462\u20131475 (2020).","journal-title":"Brain"},{"key":"436_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","volume":"32","author":"A Bloch","year":"2006","unstructured":"Bloch, A., Probst, A., Bissig, H., Adams, H. & Tolnay, M. Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol. Appl. Neurobiol. 32, 284\u2013295 (2006).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"436_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"436_CR13","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863\u20131872 (2005).","journal-title":"Neurology"},{"key":"436_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach, T. G. et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 117, 613\u2013634 (2009).","journal-title":"Acta Neuropathol."},{"key":"436_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y Saito","year":"2003","unstructured":"Saito, Y. et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. J. Neuropathol. Exp. Neurol. 62, 644\u2013654 (2003).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"436_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici, K., Rub, U., De Vos, R. A., Bohl, J. R. & Braak, H. Where does Parkinson disease pathology begin in the brain. J. Neuropathol. Exp. Neurol. 61, 413\u2013426 (2002).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"436_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/mds.26866","volume":"32","author":"K Knudsen","year":"2017","unstructured":"Knudsen, K., Krogh, K., Ostergaard, K. & Borghammer, P. Constipation in Parkinson\u2019s disease: subjective symptoms, objective markers, and new perspectives. Mov. Disord. 32, 94\u2013105 (2017).","journal-title":"Mov. Disord."},{"key":"436_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","volume":"14","author":"B Hogl","year":"2018","unstructured":"Hogl, B., Stefani, A. & Videnovic, A. Idiopathic REM sleep behaviour disorder and neurodegeneration\u2014an update. Nat. Rev. Neurol. 14, 40\u201355 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"436_CR19","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1212\/WNL.0b013e3182a6cbd5","volume":"81","author":"B Mollenhauer","year":"2013","unstructured":"Mollenhauer, B. et al. Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 81, 1226\u20131234 (2013).","journal-title":"Neurology"},{"key":"436_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/ene.13206","volume":"24","author":"JS Kim","year":"2017","unstructured":"Kim, J. S. et al. Normal \u2018heart\u2019 in Parkinson\u2019s disease: is this a distinct clinical phenotype? Eur. J. Neurol. 24, 349\u2013356 (2017).","journal-title":"Eur. J. Neurol."},{"key":"436_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3233\/JPD-150741","volume":"6","author":"DM Swallow","year":"2016","unstructured":"Swallow, D. M. et al. Variation in recent onset Parkinson\u2019s disease: implications for prodromal detection. J. Parkinson\u2019s Dis. 6, 289\u2013300 (2016).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"436_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.14802\/jmd.18037","volume":"11","author":"HR Lee","year":"2018","unstructured":"Lee, H. R., Park, J. H., Han, S. W. & Baik, J. S. Cognition, olfaction and uric acid in early de novo Parkinson\u2019s disease. J. Mov. Disord. 11, 139\u2013144 (2018).","journal-title":"J. Mov. Disord."},{"key":"436_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JPD-202481","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer, P. The alpha-synuclein origin and connectome model (SOC Model) of Parkinson\u2019s disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline. J. Parkinson\u2019s Dis. 11, 455\u2013474 (2021).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"436_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF00198957","volume":"181","author":"HP Volz","year":"1990","unstructured":"Volz, H. P. et al. Afferent connections of the nucleus centralis amygdalae. A horseradish peroxidase study and literature survey. Anat. Embryol. 181, 177\u2013194 (1990).","journal-title":"Anat. Embryol."},{"key":"436_CR25","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager, J. et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain 143, 3077\u20133088 (2020).","journal-title":"Brain"},{"key":"436_CR26","doi-asserted-by":"publisher","first-page":"105557","DOI":"10.1016\/j.nbd.2021.105557","volume":"161","author":"P Borghammer","year":"2021","unstructured":"Borghammer, P. et al. Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol. Dis. 161, 105557 (2021).","journal-title":"Neurobiol. Dis."},{"key":"436_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"SM Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad, S. M. et al. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol. 72, 863\u2013873 (2015).","journal-title":"JAMA Neurol."},{"key":"436_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75800-4","volume":"10","author":"WL Kong","year":"2020","unstructured":"Kong, W. L., Huang, Y., Qian, E. & Morris, M. J. Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson\u2019s disease over five years follow-up. Sci. Rep. 10, 19014 (2020).","journal-title":"Sci. Rep."},{"key":"436_CR29","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1007\/s00415-020-09954-6","volume":"267","author":"A Merola","year":"2020","unstructured":"Merola, A. et al. Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications. J. Neurol. 267, 2949\u20132960 (2020).","journal-title":"J. Neurol."},{"key":"436_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01928-5","volume":"20","author":"H Oka","year":"2020","unstructured":"Oka, H., Umehara, T., Nakahara, A. & Matsuno, H. Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson\u2019s disease and de novo dementia with Lewy bodies. BMC Neurol. 20, 350 (2020).","journal-title":"BMC Neurol."},{"key":"436_CR31","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/jnnp-2019-320846","volume":"90","author":"A Pilotto","year":"2019","unstructured":"Pilotto, A. et al. Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in alpha-synucleinopathies. J. Neurol. Neurosurg. Psychiatry 90, 1257\u20131263 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"436_CR32","doi-asserted-by":"publisher","first-page":"e0240491","DOI":"10.1371\/journal.pone.0240491","volume":"15","author":"R Tanaka","year":"2020","unstructured":"Tanaka, R. et al. The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson\u2019s disease. PLoS One 15, e0240491 (2020).","journal-title":"PLoS One"},{"key":"436_CR33","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma, R. B. et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142, 744\u2013759 (2019).","journal-title":"Brain"},{"key":"436_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3233\/JPD-212570","volume":"11","author":"V Leta","year":"2021","unstructured":"Leta, V. et al. Constipation is associated with development of cognitive impairment in de novo Parkinson\u2019s disease: a longitudinal analysis of two international cohorts. J. Parkinson\u2019s Dis. 11, 1209\u20131219 (2021).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"436_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1212\/WNL.51.2.363","volume":"51","author":"BF Boeve","year":"1998","unstructured":"Boeve, B. F. et al. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 51, 363\u2013370 (1998).","journal-title":"Neurology"},{"key":"436_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/mds.27997","volume":"35","author":"M van de Beek","year":"2020","unstructured":"van de Beek, M. et al. Prodromal dementia with Lewy bodies: clinical characterization and predictors of progression. Mov. Disord. 35, 859\u2013867 (2020).","journal-title":"Mov. Disord."},{"key":"436_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NRL.0b013e31827c6bdd","volume":"19","author":"WC Pao","year":"2013","unstructured":"Pao, W. C. et al. Polysomnographic findings in dementia with Lewy bodies. Neurologist 19, 1\u20136 (2013).","journal-title":"Neurologist"},{"key":"436_CR38","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","volume":"2","author":"A Vogt","year":"2017","unstructured":"Vogt, A. et al. Multiple primary tumours: challenges and approaches, a review. ESMO Open 2, e000172 (2017).","journal-title":"ESMO Open"},{"key":"436_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00441-018-2839-5","volume":"373","author":"W Peelaerts","year":"2018","unstructured":"Peelaerts, W., Bousset, L., Baekelandt, V. & Melki, R. a-Synuclein strains and seeding in Parkinson\u2019s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Cell Tissue Res. 373, 195\u2013212 (2018).","journal-title":"Cell Tissue Res."},{"key":"436_CR40","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","volume":"17","author":"K Knudsen","year":"2018","unstructured":"Knudsen, K. et al. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. 17, 618\u2013628 (2018).","journal-title":"Lancet Neurol."},{"key":"436_CR41","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1007\/s00415-019-09540-5","volume":"266","author":"S Nag","year":"2019","unstructured":"Nag, S. et al. Neocortical Lewy bodies are associated with impaired odor identification in community-dwelling elders without clinical PD. J. Neurol. 266, 3108\u20133118 (2019).","journal-title":"J. Neurol."},{"key":"436_CR42","doi-asserted-by":"publisher","unstructured":"Tremblay, C. et al. Effect of olfactory bulb pathology on olfactory function in normal aging. Brain Pathol. e13075, https:\/\/doi.org\/10.1111\/bpa.13075 (2022).","DOI":"10.1111\/bpa.13075"},{"key":"436_CR43","doi-asserted-by":"publisher","unstructured":"Sawamura, M. et al. Lewy body disease primate model with alpha-synuclein propagation from the olfactory bulb. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.29161 (2022).","DOI":"10.1002\/mds.29161"},{"key":"436_CR44","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2016.07.036","volume":"91","author":"JM Kebschull","year":"2016","unstructured":"Kebschull, J. M. et al. High-throughput mapping of single-neuron projections by sequencing of barcoded RNA. Neuron 91, 975\u2013987 (2016).","journal-title":"Neuron"},{"key":"436_CR45","doi-asserted-by":"publisher","unstructured":"Van Den Berge, N. et al. Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats. Brain, https:\/\/doi.org\/10.1093\/brain\/awab061 (2021).","DOI":"10.1093\/brain\/awab061"},{"key":"436_CR46","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J. Exp. Med. 209, 975\u2013986 (2012).","journal-title":"J. Exp. Med."},{"key":"436_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jnnp.55.2.138","volume":"55","author":"RL Doty","year":"1992","unstructured":"Doty, R. L., Stern, M. B., Pfeiffer, C., Gollomp, S. M. & Hurtig, H. I. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 55, 138\u2013142 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"436_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/jnnp.62.5.436","volume":"62","author":"CH Hawkes","year":"1997","unstructured":"Hawkes, C. H., Shephard, B. C. & Daniel, S. E. Olfactory dysfunction in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 62, 436\u2013446 (1997).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"436_CR49","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3389\/fpsyg.2015.01020","volume":"6","author":"GM Zucco","year":"2015","unstructured":"Zucco, G. M., Rovatti, F. & Stevenson, R. J. Olfactory asymmetric dysfunction in early Parkinson patients affected by unilateral disorder. Front Psychol. 6, 1020 (2015).","journal-title":"Front Psychol."},{"key":"436_CR50","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3233\/JPD-212761","volume":"11","author":"K Knudsen","year":"2021","unstructured":"Knudsen, K. et al. Asymmetric dopaminergic dysfunction in brain-first versus body-first Parkinson\u2019s disease subtypes. J. Parkinson\u2019s Dis. 11, 1677\u20131687 (2021).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"436_CR51","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","volume":"62","author":"Z Walker","year":"2004","unstructured":"Walker, Z. et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology 62, 1568\u20131572 (2004).","journal-title":"Neurology"},{"key":"436_CR52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00401-015-1451-y","volume":"130","author":"GU Hoglinger","year":"2015","unstructured":"Hoglinger, G. U. et al. A new dopaminergic nigro-olfactory projection. Acta Neuropathol. 130, 333\u2013348 (2015).","journal-title":"Acta Neuropathol."},{"key":"436_CR53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0006-8993(00)03082-1","volume":"888","author":"Y Arai","year":"2001","unstructured":"Arai, Y. et al. Alpha-synuclein-positive structures in cases with sporadic Alzheimer\u2019s disease: morphology and its relationship to tau aggregation. Brain Res 888, 287\u2013296 (2001).","journal-title":"Brain Res"},{"key":"436_CR54","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton, R. L. Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 10, 378\u2013384 (2000).","journal-title":"Brain Pathol."},{"key":"436_CR55","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo, J. B. et al. Pathological alpha-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol. 131, 393\u2013409 (2016).","journal-title":"Acta Neuropathol."},{"key":"436_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-020-02233-8","volume":"141","author":"ZI Tanei","year":"2021","unstructured":"Tanei, Z. I. et al. Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases. Acta Neuropathol. 141, 25\u201337 (2021).","journal-title":"Acta Neuropathol."},{"key":"436_CR57","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","volume":"313","author":"WJ Jansen","year":"2015","unstructured":"Jansen, W. J. et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313, 1924\u20131938 (2015).","journal-title":"JAMA"},{"key":"436_CR58","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","volume":"105","author":"F Bassil","year":"2020","unstructured":"Bassil, F. et al. Amyloid-beta (abeta) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy Body disorders with abeta pathology. Neuron 105, 260\u2013275.e266 (2020).","journal-title":"Neuron"},{"key":"436_CR59","doi-asserted-by":"publisher","first-page":"fcaa090","DOI":"10.1093\/braincomms\/fcaa090","volume":"2","author":"T Williams","year":"2020","unstructured":"Williams, T., Sorrentino, Z., Weinrich, M., Giasson, B. I. & Chakrabarty, P. Differential cross-seeding properties of tau and alpha-synuclein in mouse models of tauopathy and synucleinopathy. Brain Commun. 2, fcaa090 (2020).","journal-title":"Brain Commun."},{"key":"436_CR60","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.26191","volume":"30","author":"M Petrou","year":"2015","unstructured":"Petrou, M. et al. Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review. Mov. Disord. 30, 928\u2013935 (2015).","journal-title":"Mov. Disord."},{"key":"436_CR61","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00401-019-02071-3","volume":"138","author":"A Raunio","year":"2019","unstructured":"Raunio, A. et al. Lewy-related pathology exhibits two anatomically and genetically distinct progression patterns: a population-based study of Finns aged 85. Acta Neuropathol. 138, 771\u2013782 (2019).","journal-title":"Acta Neuropathol."},{"key":"436_CR62","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000477990","volume":"9","author":"E Stolzenberg","year":"2017","unstructured":"Stolzenberg, E. et al. A role for neuronal alpha-synuclein in gastrointestinal immunity. J. Innate Immun. 9, 456\u2013463 (2017).","journal-title":"J. Innate Immun."},{"key":"436_CR63","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0192623307313011","volume":"36","author":"L Calderon-Garciduenas","year":"2008","unstructured":"Calderon-Garciduenas, L. et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol. Pathol. 36, 289\u2013310 (2008).","journal-title":"Toxicol. Pathol."},{"key":"436_CR64","doi-asserted-by":"crossref","unstructured":"Kok, E. H. et al. Alpha-synuclein pathology of olfactory bulb\/peduncles in the Vantaa85+ cohort exhibit two divergent patterns: a population based study. Acta Neuropathol. 142, 777\u2013780 (2021).","DOI":"10.1007\/s00401-021-02364-6"},{"key":"436_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","volume":"124","author":"GG Kovacs","year":"2012","unstructured":"Kovacs, G. G. et al. An antibody with high reactivity for disease-associated alpha-synuclein reveals extensive brain pathology. Acta Neuropathol. 124, 37\u201350 (2012).","journal-title":"Acta Neuropathol."},{"key":"436_CR66","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013486 (1991).","journal-title":"Neurology"},{"key":"436_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00436-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00436-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00436-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T17:13:56Z","timestamp":1669828436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00436-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["436"],"URL":"https:\/\/doi.org\/10.1038\/s41531-022-00436-2","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"3 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}